| Previous Close | 0.2400 |
| Open | 0.2320 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 0.2300 - 0.2320 |
| 52 Week Range | 0.2000 - 0.4600 |
| Volume | 10,380 |
| Avg. Volume | 67,411 |
| Market Cap | 30.427M |
| Beta (3Y Monthly) | -0.20 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 1997-05-28 |
| 1y Target Est | N/A |
WESTMINSTER, CA / ACCESSWIRE / November 21, 2018 / BioLargo, Inc. (OTCQB: BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, today announced ...
WESTMINSTER, CA / ACCESSWIRE / November 19, 2018 / BioLargo, Inc. (BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, today announced that it had passed an important milestone - $1,000,000 in annual revenues (year-to-date in 2018). BioLargo president Dennis P. Calvert commented, "Sales of our odor control products have doubled each of the last four years. Odor-No-More, Inc. President Joseph Provenzano commented on the milestone, "We are repeatedly told by our customers we have the best odor-control product in the market.
WESTMINSTER, CA / ACCESSWIRE / November 15, 2018 / BioLargo, Inc. (OTCQB: BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, today announced ...
Dennis Calvert, CEO of BioLargo, Inc. (OTCQB:BLGO), recently spoke with Stock Day Podcast’s Everett Jolly to update listeners on the company’s recent milestones. Jolly started out the interview highlighting that BioLargo’s odor and VOC control products are set to do over $1 million in revenue in 2018. “We launched the product about two years ago into the municipal waste handling industry,” Calvert explains to Uptick.
WESTMINSTER, Calif., Oct. 31, 2018 -- BioLargo, Inc. (OTCQB:BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, today.
WESTMINSTER, Calif., Oct. 22, 2018 -- BioLargo, Inc. (OTCQB:BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, today.
BioLargo, Inc. (BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, announced today that it had entered into definitive agreements to acquire a breakthrough stem cell therapy technology called “SkinDisc.” Developed by Scion Solutions, LLC, SkinDisc uses a patient’s own bone marrow and plasma to generate a cell-rich biogel which heals chronic wounds. The SkinDisc product will be sold through BioLargo subsidiary Clyra Medical Technologies, Inc. In addition to the SkinDisc product, Scion’s key team members will join Clyra to support Clyra’s commercial strategy, including Dr. Brock Liden, a renowned medical podiatrist and expert in wound care and diabetic limb salvage, and Spencer Brown, a medical device industry veteran with more than 35 years of experience working in medical sales, account management, and distribution in the medical device industry.
WESTMINSTER, Calif., Sept. 25, 2018 -- BioLargo, Inc. (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company,.
LOS ANGELES, CA / ACCESSWIRE / June 1, 2018 / BioLargo, Inc. (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company today announced that it ...
WESTMINSTER, CA / ACCESSWIRE / April 20, 2018 / BioLargo, Inc., (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, will present at the ...
LOS ANGELES, CA / ACCESSWIRE / March 7, 2018 / BioLargo, Inc. (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, today announced that ...